ENZY.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$109M	+39.7%	$-0.30	$-0.30–$-0.30	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ENZY.STEnzymatica AB (publ)	$1.91	+0.53%	$464M	—
ACE.STAscelia Pharma AB (publ)	$0.61	-1.93%	$81M	—
ALZCUR.STAlzeCure Pharma AB	$7.96	-0.50%	$1.0B	—
CLBIO.STCorline Biomedical AB	$15.15	-0.33%	$396M	—
ERMA.STEnorama Pharma AB (publ)	$0.71	-10.58%	$53M	—
FLUO.STFluoGuide A/S	$33.40	+0.60%	$546M	—
IMMU.STMendus AB (publ)	$6.22	-6.33%	$381M	—

Source: Financial Modeling Prep · peers by sector/industry

Enzymatica AB (publ)

Enzymatica AB, a life science company headquartered in Lund, Sweden, focuses on the development and sale of medical devices for infection-related illnesses. Founded in 2007, its primary offering is the ColdZyme mouth spray, designed to help prevent and reduce the duration of the common cold. The company also produces various enzyme formulations. This mouth spray is distributed across several European markets under different brand names: ViruProtect in Denmark, STADAProtect in Germany, Psysiomer Stop Virus in France, and Zerinol Virus Defense in Italy.

www.enzymatica.com

Employees: 18
IPO / List date: Jun 14, 2011
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ENZY.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ENZY.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ENZY.ST yet.